Health Care: Drugs

Dynavax Technologies Corp (DVAX: NASDAQ)

$21.74 n/a | n/a%
05/22/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 20.21
52 Week High 26.89
52 Week Low 12.80
Avg. Daily Vol. (Mil) 0.43
Beta (3 year) 2.76
Share Related Items
Mkt Cap (Mil) 592.22
Shares Out (Mil) 29.30
Float (Mil) 25.03
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.80
Current Ratio 5.00
LT Debt/ Equity 0.12
Total Debt / Equity 0.13
Valuation Ratios
Price Earnings n.a.
Price/Sales 72.57
Price/Book 7.89
Price/Cash Flow -5.90
Per Share Data
Earnings -3.89
Sales 0.28
Book Value 2.56
Cash Flow -3.44
Business Summary
Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The Company is engaged in thedevelopment for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer.
General Information
2929 Seventh Street
Suite 100
Berkeley, CA 94710-2753
www.dynavax.com
Industry : Drugs
Sector: Health Care
Employees: 197
CEO: Eddie Gray
Short Interest
Current Month (Mil) 6.66
Previous Month (Mil) 6.44
Short Interest Ratio (Days) 16.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -91.90
Return on Investments -122.80
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with DVAX

Latest DVAX Headlines from TheStreet

More Financial News for DVAX

Press Releases for DVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter